GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Life Sciences Ltd (NSE:GLS) » Definitions » Pre-Tax Income

Glenmark Life Sciences (NSE:GLS) Pre-Tax Income : ₹5,681 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Glenmark Life Sciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Glenmark Life Sciences's pretax income for the three months ended in Sep. 2024 was ₹1,275 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was ₹5,681 Mil. Glenmark Life Sciences's pretax margin was 25.15%.

During the past 6 years, Glenmark Life Sciences's highest Pretax Margin was 30.70%. The lowest was 25.30%. And the median was 28.54%.


Glenmark Life Sciences Pre-Tax Income Historical Data

The historical data trend for Glenmark Life Sciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Life Sciences Pre-Tax Income Chart

Glenmark Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
Get a 7-Day Free Trial 4,210.67 4,709.44 5,649.25 6,286.09 6,312.90

Glenmark Life Sciences Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,589.25 1,606.83 1,296.78 1,502.38 1,274.56

Competitive Comparison of Glenmark Life Sciences's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Life Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glenmark Life Sciences's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glenmark Life Sciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Glenmark Life Sciences's Pre-Tax Income falls into.



Glenmark Life Sciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Glenmark Life Sciences's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=6221.35+0+-15.46+120.21+-13.200000000001
=6,313

Glenmark Life Sciences's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=1192.66+0+-3.43+0+85.33
=1,275

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,681 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glenmark Life Sciences  (NSE:GLS) Pre-Tax Income Explanation

Glenmark Life Sciences's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=1274.56/5068.79
=25.15%

During the past 6 years, Glenmark Life Sciences's highest Pretax Margin was 30.70%. The lowest was 25.30%. And the median was 28.54%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glenmark Life Sciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Glenmark Life Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Glenmark Life Sciences Business Description

Traded in Other Exchanges
Address
470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400099
Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Glenmark Life Sciences Headlines

No Headlines